Shares of Eupraxia Pharmaceuticals Inc. (OTCMKTS:EPRXF – Get Free Report) fell 1.1% during trading on Friday . The stock traded as low as C$3.88 and last traded at C$3.89. 13,528 shares traded hands during mid-day trading, an increase of 83% from the average session volume of 7,410 shares. The stock had previously closed at C$3.93.
Eupraxia Pharmaceuticals Price Performance
The firm’s fifty day moving average price is C$3.69 and its 200 day moving average price is C$3.48.
About Eupraxia Pharmaceuticals
Eupraxia Pharmaceuticals Inc, a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis.
Read More
- Five stocks we like better than Eupraxia Pharmaceuticals
- Airline Stocks – Top Airline Stocks to Buy Now
- IBM Up 10 Days in a Row: What’s Driving the Winning Streak?
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Upstart Stock’s Bull Case Just Got a Lot Stronger
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Higher Gulf Oil Output Puts These Energy Names in Play
Receive News & Ratings for Eupraxia Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eupraxia Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
